The Importance of Continued Investment in R&D
September 2nd 2013There has been a notable shift in interest for life-science companies over recent months from institutional investors investing through the public markets, but any plans to release further capital will rely on first-rate R&D.
Advancing Chiral Chemistry in Pharmaceutical Synthesis
September 2nd 2013Developments involve stereoretentive cross-coupling, enantioselective alcohol silylation, strategies for amplifying signals in circular dichroism spectroscopy, and a synthetic route for the natural product ingenol.